[COVID-19 Update] Early Results of Sinovac's Coronavirus Vaccine Show 90% of Volunteers Developed Antibodies The Beijing-based Sinovac Biotech Ltd. claims to have positive early data from their human trials of its COVID-19 vaccine with more than 90% of trial participants developing antibodies after two weeks. by CJ Robles
Health Coronavirus Cure: Doctors Discover Life-Saving COVID-19 Treatment in the Form of Actemra by Nhx Tingson